HanAll Biopharma Sponsors 17 million KRW worth Daily Supplies to Patients with Xerosis
HanAll Biopharma Sponsors 17 million KRW worth Daily Supplies to Patients with Xerosis
HanAll Biopharma Sponsors Medicines worth 82 million KRW to Community Chest of Korea
HanAll Biopharma Sponsors Medicines worth 82 million KRW to Community Chest of Korea
Hanall Biopharma Received the \'2014 Grand Prize of King Sejong Voluntary Service of Sharing\'
Hanall Biopharma Received the \'2014 Grand Prize of King Sejong Voluntary Service of Sharing\'
HanAll is Entering into the 60 Billion KRW Market with Peptic Ulcer Drug “Wibis Tab”
HanAll is Entering into the 60 Billion KRW Market with Peptic Ulcer Drug “Wibis Tab”
HanAll Biopharma Records Surplus for Three Consecutive Quarter
HanAll Biopharma Records Surplus for Three Consecutive Quarter
HanAll Completed the CGMP-class Production Plant for Cutting-edge Solid Formula
HanAll Completed the CGMP-class Production Plant for Cutting-edge Solid Formula